Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma

Visceral Adiposity as a Significant Predictor of Sunitinib-Induced Dose-Limiting Toxicities and Survival in Patients with Metastatic Clear Cell Renal Cell Carcinoma

Sunitinib is a first-line treatment for metastatic renal cell carcinoma (mRCC). Little is known about the predictive factors of sunitinib-induced dose-limiting toxicity (DLT) in Asian populations. We investigated whether body composition predicts sunitinib-induced DLT. We retrospectively reviewed su...

Full description

Bibliographic Details
Main Authors: Jee Soo Park, Kyo Chul Koo, Doo Yong Chung, Sun Il Kim, Jeongho Kim, Cheol Kyu Oh, Tae Nam Kim, Sung Ku Kang, Jae Won Park, Young Eun Yoon, Sung Yul Park, Koon Ho Rha, Won Sik Ham
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
dose-limiting toxicity
obesity
renal cell carcinoma
sunitinib
visceral adiposity
Online Access:https://www.mdpi.com/2072-6694/12/12/3602

Internet

https://www.mdpi.com/2072-6694/12/12/3602

Similar Items